Capitalizator.

Capitalize Yourself: Right Data. Real Growth.

Company Analysis

CLRB Insider Trading

Cellectar Biosciences, Inc. | Pharmaceutical Preparations

Comprehensive Trading Performance Summary

The investment history of corporate insiders at Cellectar Biosciences, Inc. provides a unique lens into the internal conviction of the company's leadership. By analyzing SEC Form 4 filings, investors can track how directors and officers are allocating their own capital. High-conviction buying often signals that management believes the current market price significantly undervalues future growth prospects, while strategic selling might occur for personal liquidity or portfolio diversification. Monitoring these shifts in ownership is essential for understanding the alignment between management and shareholders in the Pharmaceutical Preparations sector.

Last 7 Days
$0
Buys
$0
Sells
Last 30 Days Trend
$0
Buys
$0
Sells

Transactions on Chart

Open Full Chart
Filing Date Trade Date Reporting Person Relationship Type Price Qty Total, $ Owned After Change, %
2025-12-17 02:00 2025-12-12 NEIS JOHN Director SELL $3.70 198 $732 10 -95.2%
2025-07-03 15:02 2025-07-02 CARUSO JAMES V Director, Officer - Chief Executive Officer BUY $4.99 10,000 $49,900 11,638 +610.5%
2025-07-03 15:01 2025-07-02 Longcor Jarrod Officer - Chief Operating Officer BUY $4.99 10,000 $49,900 12,768 +361.3%
2025-07-03 15:00 2025-07-02 Kolean Chad J Officer - Chief Financial Officer BUY $4.99 5,000 $24,950 6,418 +352.6%
2025-03-13 04:44 2025-01-10 Longcor Jarrod Officer - Chief Operating Officer BUY $0.28 30,000 $8,400 83,141 +56.5%
2021-09-14 23:00 2021-09-14 Swirsky Douglas J Director BUY $1.04 25,000 $26,000 25,000 +100.0%
2021-09-07 23:01 2021-09-03 DRISCOLL FREDERICK W Director BUY $1.04 19,417 $20,244 19,417 +100.0%
2021-03-06 01:45 2021-03-04 CARUSO JAMES V Director, Officer - President and CEO BUY $1.70 5,100 $8,659 86,401 +6.3%
2020-12-29 00:31 2020-12-28 CARUSO JAMES V Director, Officer - President and CEO BUY $1.35 37,037 $50,000 81,301 +83.7%
2020-12-29 00:31 2020-12-28 Longcor Jarrod Officer - Chief Business Officer BUY $1.35 29,630 $40,001 102,148 +40.9%
2020-12-29 00:30 2020-12-28 Elefant Dov Officer - Chief Financial Officer BUY $1.35 7,407 $9,999 11,755 +170.4%
2020-06-08 23:12 2020-06-04 HILL STEPHEN A Director BUY $1.08 18,000 $19,438 18,000 +100.0%
2020-06-08 23:08 2020-06-05 Elefant Dov Officer - Chief Financial Officer BUY $1.15 4,348 $4,978 4,348 +100.0%
2020-06-08 23:08 2020-06-05 Longcor Jarrod Officer - Chief Business Officer BUY $1.15 65,218 $74,675 72,518 +893.4%
2020-06-08 23:07 2020-06-05 CARUSO JAMES V Director, Officer - President and CEO BUY $1.15 21,740 $24,892 44,264 +96.5%
2019-03-02 00:20 2019-02-28 Longcor Jarrod Officer - Chief Business Officer BUY $2.00 100 $200 7,300 +1.4%
2018-12-01 02:23 2018-11-30 CARUSO JAMES V Director, Officer - President and CEO BUY $2.28 1,000 $2,282 22,354 +4.7%
2018-12-01 02:19 2018-11-29 HILL STEPHEN A Director SELL $2.21 992 $2,192 0 -100.0%
2018-08-18 01:14 2018-08-16 Longcor Jarrod Officer - Chief Business Officer BUY $2.71 500 $1,355 7,200 +7.5%
2018-03-14 23:01 2018-03-13 Longcor Jarrod Officer - Chief Business Officer SELL $1.18 13,000 $15,397 67,000 -16.3%
2018-03-14 23:01 2018-03-12 CARUSO JAMES V Director, Officer - President and CEO SELL $1.20 34,000 $40,705 213,548 -13.7%
2017-11-17 00:04 2017-11-14 NEIS JOHN Director SELL $1.49 5,214 $7,791 626,103 -0.8%
2016-12-01 02:59 2016-11-29 NEIS JOHN Director BUY $1.49 333,333 $496,666 631,317 +111.9%
2016-11-02 03:45 2016-10-31 Hertzberg Richard Other SELL $2.03 21,000 $42,609 280,000 -7.0%
2016-06-15 02:13 2016-04-15 Hertzberg Richard Other BUY $2.12 238,500 $504,785 301,000 +381.6%
2016-04-22 01:04 2016-04-20 HILL STEPHEN A Director BUY $2.12 9,390 $19,907 9,920 +1,771.7%
2016-04-22 01:03 2016-04-20 NEIS JOHN Director BUY $2.12 234,742 $497,653 297,984 +371.2%
2016-04-22 01:01 2016-04-20 BERNS PAUL L Director BUY $2.12 117,371 $248,827 117,371 +100.0%
2016-04-22 01:00 2016-04-20 CARUSO JAMES V Director, Officer - President and CEO BUY $2.12 46,948 $99,530 47,548 +7,824.7%
2016-01-05 00:29 2015-12-30 AWM Investment Company, Inc. 10% owner SELL $0.69 100,000 $69,020 0 -100.0%
2015-12-30 23:41 2015-12-29 AWM Investment Company, Inc. 10% owner SELL $0.69 82,847 $57,405 100,000 -45.3%
2015-12-30 00:28 2015-12-24 AWM Investment Company, Inc. 10% owner SELL $0.73 367,966 $269,057 182,847 -66.8%
2015-12-23 23:45 2015-12-22 AWM Investment Company, Inc. 10% owner SELL $0.90 7,938 $7,181 550,813 -1.4%
2015-12-23 00:05 2015-12-18 AWM Investment Company, Inc. 10% owner SELL $0.92 27,621 $25,309 558,751 -4.7%
2015-12-19 00:40 2015-12-16 AWM Investment Company, Inc. 10% owner SELL $0.87 71,225 $61,880 586,372 -10.8%
2015-12-16 23:50 2015-12-15 AWM Investment Company, Inc. 10% owner SELL $0.82 44,965 $37,065 657,597 -6.4%
2015-12-09 00:29 2015-12-04 AWM Investment Company, Inc. 10% owner SELL $1.06 50,950 $54,180 702,562 -6.8%
2015-12-03 23:35 2015-12-01 AWM Investment Company, Inc. 10% owner SELL $1.04 42,110 $43,815 753,512 -5.3%
2015-12-02 00:38 2015-11-25 AWM Investment Company, Inc. 10% owner SELL $1.20 4,378 $5,265 795,622 -0.5%
2015-11-25 23:58 2015-11-23 AWM Investment Company, Inc. 10% owner SELL $1.24 173,802 $214,750 800,000 -17.8%
2015-11-25 20:29 2015-11-24 CARUSO JAMES V Director, Officer - President and CEO BUY $1.30 1,000 $1,302 6,000 +20.0%
2015-11-25 02:32 2015-11-20 CARUSO JAMES V Director, Officer - President and CEO BUY $1.16 1,000 $1,159 5,000 +25.0%
2015-11-23 23:09 2015-11-19 AWM Investment Company, Inc. 10% owner SELL $1.17 96,806 $113,340 973,802 -9.0%
2015-11-20 03:17 2015-11-18 CARUSO JAMES V Director, Officer - President and CEO BUY $1.45 4,000 $5,790 4,000 +100.0%
2015-10-29 23:48 2015-10-28 AWM Investment Company, Inc. 10% owner SELL $2.00 99 $198 1,070,608 0.0%
2015-10-26 23:46 2015-10-22 AWM Investment Company, Inc. 10% owner SELL $2.00 8,866 $17,732 1,070,707 -0.8%
2015-10-08 23:14 2015-10-06 AWM Investment Company, Inc. 10% owner SELL $2.00 2,554 $5,108 1,079,573 -0.2%
2015-10-06 23:18 2015-10-02 AWM Investment Company, Inc. 10% owner SELL $2.04 7,500 $15,303 1,082,127 -0.7%
2015-10-02 23:26 2015-09-30 AWM Investment Company, Inc. 10% owner SELL $2.05 27,940 $57,174 1,089,627 -2.5%
2015-09-30 23:18 2015-09-28 AWM Investment Company, Inc. 10% owner SELL $2.36 24,801 $58,582 1,117,567 -2.2%
SHOW ENTRIES
1-50 OF 55

How to Interpret $CLRB Trades

Not every insider transaction in Cellectar Biosciences, Inc. is a signal for immediate action. Professional investors look for "cluster buying"—when multiple executives simultaneously purchase $CLRB shares on the open market. It is crucial to distinguish between scheduled sales (under Rule 10b5-1) and voluntary increases in ownership, which demonstrate management’s true conviction that the stock is undervalued.

Data Source & Accuracy for CLRB

Insider activity data for Cellectar Biosciences, Inc. is streamed in real-time directly from the SEC EDGAR system. We analyze raw Form 4 filings, filtering out technical adjustments and complex derivative transactions. This provides a transparent view of how ownership structure is evolving in $CLRB, allowing you to follow the capital of those with the most intimate knowledge of the company.

UNDERSTANDING THE DATA

FILING DATE: The date and time when the transaction was reported to the SEC. This is when the public first receives the information.

TRADE DATE: The actual day the insider executed the purchase or sale in the market.

INDUSTRY: The specific market sector the company operates in. Useful for identifying broader institutional capital flows across sectors.

OWNED AFTER: The total number of shares held by the insider following the transaction. This highlights the insider's remaining conviction in the company.

CHANGE %: The percentage increase or decrease of the insider's total position. Large percentage changes often carry more weight than the dollar amount alone.

TRADE TYPES DEFINITIONS

BUY: An open market purchase. Typically indicates an insider's belief that the stock is undervalued or poised for growth.

SELL: An open market sale. While often used for diversification or liquidity, large or unexpected sales can be a warning signal.

OPT+S (OPTION EXERCISE & SALE): This occurs when an insider exercises their stock options and sells them immediately. Often part of a structured compensation plan.